INTRODUCTION
============

Patient-reported outcome measures (PROMs) were originally used to assess treatment effectiveness within clinical trials \[[@hnaa002-B1]\]. However, the use of PROMs has evolved into tools that allow healthcare providers to evaluate the effects of their interventions by gaining their patients perspective in a reliable, valid and acceptable way \[[@hnaa002-B2]\]. The Hip Outcome Score (HOS) and the International Hip Outcome Tool-12 (iHOT12) are two commonly used measures for hip disabilities \[[@hnaa002-B3]\]. Both validated measures, the IHOT12 was designed to assess non-arthritic hip problems in young, active patients, while the HOS was designed to assess the treatment outcomes of arthroscopic hip surgery \[[@hnaa002-B4]\].

PROMS have become acceptable and routine within the healthcare industry because they are informative and observer bias is limited since patients give their perspective on their health condition \[[@hnaa002-B8]\]. Both healthcare providers and researchers utilize these measures to evaluate hip pathologies and the acquired data can be used for scientific investigations \[[@hnaa002-B12]\]. In a systematic review by Thorborg *et al*. \[[@hnaa002-B3]\], nine PROMs were identified for assessing young to middle-aged adults with hip disability. Although several PROMS are available, it would not be feasible or necessary to administer multiple surveys to patients due to administrative and respondent burden \[[@hnaa002-B9], [@hnaa002-B15]\].

To address this, we compared scores of two hip PROMs, the HOS and the iHOT12. Our purpose was to determine if scores of the iHOT12 and the HOS correlate with one another in hip pain patients. We hypothesized that there would be a correlation between the scores of the HOS and iHOT12.

METHODS
=======

The University of Minnesota Institutional Review Board approved this investigation. The sample consisted of patients of the senior author, a sports fellowship trained orthopedic surgeon with 20 years of hip arthroscopy experience, from July 2017 to January 2019. Patients were included in this study if they reported for their scheduled orthopedic appointment for hip pain and were patients of the senior author and voluntarily agreed to participate in the study. Patients without hip pain, patients of another provider and patients that refused study participation were excluded. Patients that met the inclusion criteria received a packet containing an informed consent form and a survey that consisted of the HOS with ADL subscale and iHOT12 when they arrived for their appointment. After the patient voluntarily completed the informed consent form and survey by hand, demographic information \[age, weight, height and body mass index (BMI)\] was collected through chart review. The PROMS were then hand scored and entered into an excel spreadsheet.

A total of 114 patients were invited to voluntarily complete the surveys in which 23 refused; therefore, our final sample consisted of 91 (57 female and 34 male) patients (80% response rate). Of this sample, 25 of the 91 patients were diagnosed with osteoarthritis.

Statistical analysis
--------------------

An *a priori* power analysis was performed using the program G\*Power \[[@hnaa002-B16]\]. This analysis indicated that a sample size of 84 patients was needed to provide 80% statistical power to determine a medium effect size (*α* = 0.05). Multiple linear regression analyses with indicator variable corresponding to gender were used to explain iHOT12 and HOS by using age, weight, BMI, gender and arthritis. To model the predictive power of iHOT12 and HOS on each other various linear models were used, some including gender. Also, correlation analyses by using Pearson's correlation, *r*, was carried out used to understand the relationships between the scores of the iHOT12 and HOS, BMI and HOS scores; BMI and iHOT12 scores; age and HOS scores; and age and iHOT12 scores. Statistical software program R was utilized for all of the analyses.

RESULTS
=======

See [Table I](#hnaa002-T1){ref-type="table"} for demographic data. The HOS (iHOT12) explained 62% of the variation in iHOT12 (HOS) by using a linear model (Pearson's correlation (*r*) is 0.79, *P* \< 0.001). Age, weight, BMI, gender and arthritis did not show a statistically significant predictive power explaining HOS ([Table II](#hnaa002-T2){ref-type="table"}). On the other hand, only gender had a 'statistically' significant predictive power explaining iHOT12 (*P* = 0.007). As it can be seen in [Table III](#hnaa002-T3){ref-type="table"}, the relationship between the two scores are stronger for males (*r* = 0.81, *P* \< 0.001) compared with females (*r* = 0.77, *P* \< 0.001). In other words, the proportion of variations explained on one of the scores by the other are 0.66 for males and 0.59 for females ([Tables IV--VI](#hnaa002-T4){ref-type="table"}). HOS score together with gender explained 64% of the variation in iHOT12 by using a linear model ([Fig. 1](#hnaa002-F1){ref-type="fig"} and [Table VII](#hnaa002-T7){ref-type="table"}). On the other hand, iHOT12 together with the non-statistically significant gender term explained 62% of the variation in HOS by using a linear model ([Table VIII](#hnaa002-T8){ref-type="table"}). iHOT12 and HOS scores for the arthritic and non-arthritic patients were not statistically different ([Table IX](#hnaa002-T9){ref-type="table"}.)

![The scatter plot of iHOT12 versus HOS controlling for the gender.](hnaa002f1){#hnaa002-F1}

###### 

Demographic data

                  Mean     Median   Range  SD
  --------------- ------- -------- ------- -------
  BMI             27.41     24.8    30.83  5.81
  Age             43.63      45      64    16.79
  iHOT12 scores                            
   Overall        5.2       5.08     8.2   2.12
   Female         4.77      4.33    8.05   2.03
   Male           5.92      5.77    6.78   2.11
  HOS scores                               
   Overall        64.33      65     87.5   19.46
   Female         61.9     63.24    87.5   20.02
   Male           68.41    68.16    65.81  18.04

BMI, body mass index; iHOT, international hip outcome tool; HOS, hip outcome score; SD, standard deviation.

###### 

The results of multiple regression analyses for predicting IHOT and HOS scores by using age, weight, IBM and gender

                            iHOT          HOS                                                    
  ------------------------- ------------- --------------- ------------- ------- ---------------- -------------
  Intercept                 4.85          2.59 to 7.11    **\<0.001**   71.33   49.90 to 92.75   **\<0.001**
  Age                       0.02          −0.01 to 0.04   0.290         0.03    −0.24 to 0.31    0.800
  Weight                    0.01          −0.01 to 0.04   0.251         0.01    −0.20 to 0.22    0.917
  BMI                       −0.11         −0.26 to 0.04   0.154         −0.43   −1.86 to 0.99    0.545
  Sex: male                 1.26          0.33 to 2.19    **0.009**     6.06    −2.74 to 14.85   0.175
  Arthritis: yes            −0.33         −1.39 to 0.73   0.536         −2.73   −12.73 to 7.28   0.589
  Observations              91            91                                                     
  *R* ^2^/*R*^2^ adjusted   0.102/0.049   0.043/−0.014                                           

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of regression analysis for predicting IHOT score by using HOS score controlling for the gender

                            iHOT (female)   iHOT (male)                                           
  ------------------------- --------------- --------------- ------------- ------- --------------- -------------
  Intercept                 −0.08           −1.21 to 1.05   0.889         −0.58   −2.32 to 1.15   0.498
  HOS                       0.08            0.06 to 0.10    **\<0.001**   0.10    0.07 to 0.12    **\<0.001**
  Observations              57              34                                                    
  *R* ^2^/*R*^2^ adjusted   0.597/0.590     0.661/0.651                                           

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of the linear models to explain the impact of gender on iHOT and HOS scores

                 iHOT   HOS                                                   
  -------------- ------ -------------- ------------- ------- ---------------- -------------
  Intercept      4.77   4.23 to 5.31   **\<0.001**   61.90   56.82 to 66.99   **\<0.001**
  Sex: male      1.15   0.27 to 2.04   **0.011**     6.50    −1.81 to 14.82   0.124
  Observations   91     91                                                    

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of multiple regression analysis for predicting IHOT score through gender and HOS score

                            iHOT                          
  ------------------------- ------------- --------------- -------------
  Intercept                 −0.42         −1.34 to 0.51   0.377
  Sex: male                 0.61          0.05 to 1.17    **0.034**
  HOS                       0.08          0.07 to 0.10    **\<0.001**
  Observations              91                            
  *R* ^2^/*R*^2^ adjusted   0.644/0.635                   

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of multiple regression analysis for predicting HOS score through gender and IHOT score

                            HOS                            
  ------------------------- ------------- ---------------- -------------
  Intercept                 26.78         20.12 to 33.44   **\<0.001**
  Sex: male                 −1.98         −7.35 to 3.38    0.464
  iHOT                      7.36          6.13 to 8.59     **\<0.001**
  Observations              91                             
  *R* ^2^/*R*^2^ adjusted   0.627/0.618                    

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of regression analysis for predicting HOS score by using IHOT score

                            HOS                            
  ------------------------- ------------- ---------------- -------------
  Intercept                 26.66         20.02 to 33.30   **\<0.001**
  IHOT12 score              7.24          6.06 to 8.43     **\<0.001**
  Observations              91                             
  *R* ^2^/*R*^2^ adjusted   0.625/0.620                    

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of regression analysis for predicting IHOT score by using HOS score

                            iHOT                          
  ------------------------- ------------- --------------- -------------
  Intercept                 −0.35         −1.29 to 0.60   0.468
  HOS                       0.09          0.07 to 0.10    **\<0.001**
  Observations              91                            
  *R* ^2^/*R*^2^ adjusted   0.625/0.620                   

*Note*: Bold values are just to emphasize the statistically significant model terms.

###### 

The results of the linear models to explain the impact of arthritis on iHOT and HOS scores

                   iHOT    HOS                                                    
  ---------------- ------- --------------- ------------- ------- ---------------- -------------
  Intercept        5.28    4.76 to 5.80    **\<0.001**   65.44   60.67 to 70.20   **\<0.001**
  Arthritis: yes   −0.28   −1.27 to 0.72   0.584         −4.01   −13.10 to 5.09   0.384
  Observations     91      91                                                     

*Note*: Bold values are just to emphasize the statistically significant model terms.

DISCUSSION
==========

By comparing the measurement properties of the HOS with the iHOT12 in patients that reported to an orthopedic clinic complaining of hip pain, we found that these two measurements are closely related with each other. Age, weight and BMI did not show a statistically significant relationship with these measures. Our analysis showed that there is a statistically significant difference between genders for the HOS but not for iHOT12 (see [Table IV](#hnaa002-T4){ref-type="table"}). Our study suggests that it may not be necessary to collect both the iHOT12 and HOS in clinical setting, since the predictive power of one on the other is high. Collecting HOS together with information on gender is preferable compared with collecting iHOT12.

We found that the scores of the iHOT12 and the HOS correlated with one another; however, one must take into consideration what patients and situations each instrument was intended for and the psychometric properties of each instrument \[[@hnaa002-B9]\]. According to Griffin *et al*. \[[@hnaa002-B4]\], the iHOT was developed to provide an evaluation tool for the management of non-arthritic hip problems in young, active patients for use in clinical practice to gain patient perspective for both initial assessment and postoperative follow-up care. This measure is a shorter version of the iHOT 33 with the same questionnaire characteristics with evidence of validity, reliability and responsiveness to change \[[@hnaa002-B4]\]. In contrast, including both subscales (activities of daily living and sports), the HOS has been deemed valid for use following hip arthroscopy and for use with patients enduring hip labral tears \[[@hnaa002-B5], [@hnaa002-B6]\]. There is evidence of reliability and responsiveness \[[@hnaa002-B7]\]. Martin *et al*. \[[@hnaa002-B5]\] reported that both of the HOS subscales had adequate internal consistency, were potentially responsive across the spectrum of ability, and contributed information across the spectrum of ability.

Considering the psychometric properties of both instruments and the strong correlation between scores, our results suggest that administering only one of these measures can provide useful information to the provider. This is because both of these instruments measure similar characteristics and administering both simultaneously may not provide additional information. Furthermore, collecting both measures presents a burden to the patient due to the increased number of requested answers and the time required to respond to the questions \[[@hnaa002-B9]\]. For routine clinical practice including initial assessment and postoperative follow-up, we suggest that the HOS is appropriate in this setting.

Within the literature, correlations between scores of physician-assessed and patient-assessed outcomes have been identified. Kalairajah *et al*. \[[@hnaa002-B17]\] compared the scores of Harris Hip Score (a physician-assessed measure) to the scores of the Oxford hip score (a PROM) and found a good negative correlation between scores. The results of their study and of ours suggest that it may be possible to identify a single outcome measure for with patients with hip pathologies.

Limitations
-----------

There are several limitations to this study. First, our study surveyed patients that were experiencing hip pain in an orthopedic clinic. Our findings may be different in patients with specific injuries. Secondly, since there were more females than males, we were unable to compare data between genders. Third, participants of this study were from the Midwestern United States, which may reduce generalizability when compared with other settings. Fourth, hand-scoring of surveys may introduce measurement bias.

CONCLUSION
==========

It may not be necessary to collect both the iHOT12 and HOS, since the predictive power of one on the other is high. Collecting HOS together with information on gender is preferable compared with collecting iHOT12.
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